Oral Suspension definition

Oral Suspension means a finished pharmaceutical preparation containing the Drug Substance as an active ingredient, consisting of a dosage formulation of the Drug Substance suspended in a liquid for delivery by mouth.
View Source
Oral Suspension means a liquid preparation that consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble and that is intended to be administered orally.
View Source

Examples of Oral Suspension in a sentence

  • As a specific activity under the Development Program, the parties will collaborate to complete development of an Oral Suspension, with the goal of maximizing efficiency and controlling Development Costs by utilizing the expertise and existing resources of each of the parties.

  • During the Pre-Launch Period with respect to the Oral Suspension, Replidyne shall use its Commercially Reasonable Efforts to engage and organize the Replidyne Pediatrician Sales Force in accordance with strategic plans agreed to by the JMC and provided in the Marketing Plan.

  • Replidyne reserves the right to terminate its Pediatrician Promotion Rights at any time during the Pediatrician Promotion Period, effective upon eighteen (18) months written notice to Forest, or immediately upon written notice to Forest if Replidyne believes that a recall, market withdrawal or other corrective action related to the Oral Suspension is warranted in the Territory.

  • If Forest makes such a determination, it shall have the right to cease all sales of Oral Suspension in the Territory and the promotion and Detailing of the Oral Suspension in the Territory immediately upon written notice to Replidyne.

  • On a periodic basis, Forest will provide Replidyne with copies of product technical complaints regarding the Oral Suspension and the results of Forest’s investigations of such complaints.

  • In the U.S., ZEGERID Capsules and ZEGERID Powder for Oral Suspension are indicated for the treatment of heartburn and other symptoms associated with gastroesophageal reflux disease (GERD), erosive esophagitis, and gastric and duodenal ulcers.

  • The parties acknowledge that additional promotional efforts following the First Commercial Sale of an Oral Suspension is warranted to increase awareness of the commercial availability of that additional Product.

  • The IND and NDA for the Oral Suspension will be filed in Replidyne’s name, and Replidyne shall hold the NDA and any subsequent supplemental NDAs for the Oral Suspension until approval of the NDA for the Oral Suspension, at which time Forest will become the holder of such NDA.

  • Unlike delayed-release PPIs, ZEGERID Capsules and Powder for Oral Suspension utilize an antacid in lieu of an enteric coating.

  • Forest’s promotional efforts to non-Pediatricians with respect to the Oral Suspension will be performed in conjunction with the promotion of the Tablet to such physicians.